| Caplin Point Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524742 |
NSE Symbol : CAPLIPOINT |
P/E(TTM) : 41.66 |
|
ISIN Demat : INE475E01026 |
Div & Yield% : 0.35 |
EPS(TTM) : 55.22 |
|
Book Value(₹) : 269.76 |
Market Cap(₹Cr) : 17,484.21 |
Face Value(₹) : 2.00 |
| Particulars | Dec '26 | Dec '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 738.33 | 752.41 | 625.09 | 528.61 | 528.06 |
| Other Income | 195.37 | 134.59 | 105.84 | 99.00 | 56.55 |
| Stock Adjustments | 12.37 | -24.36 | 43.68 | 1.67 | 9.00 |
| Total Income | 946.07 | 862.64 | 774.61 | 629.28 | 593.61 |
| EXPENDITURE : | |||||
| Raw Materials | 241.33 | 213.81 | 248.90 | 199.73 | 213.65 |
| Power and Fuel Cost | 13.64 | 14.11 | 15.43 | 9.89 | 9.54 |
| Other Manufacturing Expenses | 27.05 | 24.00 | 25.43 | 13.73 | 10.81 |
| Selling and Administration Expenses | 65.81 | 75.50 | 40.75 | 40.30 | 43.51 |
| Miscellaneous Expenses | 17.37 | 16.53 | 13.07 | 10.03 | 9.46 |
| Employee Benefit Expenses | 47.72 | 52.13 | 38.11 | 36.68 | 30.47 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 533.15 | 466.56 | 392.92 | 318.92 | 276.17 |
| Interest | 0.20 | 0.12 | 0.10 | 0.12 | 0.09 |
| Gross Profit | 532.95 | 466.44 | 392.82 | 318.80 | 276.08 |
| Depreciation | 25.43 | 24.77 | 27.08 | 25.65 | 25.77 |
| Profit Before Tax | 507.52 | 441.67 | 365.74 | 293.15 | 250.31 |
| Current Tax | 109.49 | 102.90 | 86.12 | 66.58 | 61.62 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 1.45 | -0.72 | -4.09 | -7.69 | 0.82 |
| Reported Net Profit | 396.58 | 339.49 | 283.71 | 234.26 | 187.87 |
| Extraordinary Items | 13.29 | -0.33 | 1.19 | 1.17 | 0.75 |
| Adjusted Net Profit | 383.29 | 339.82 | 282.52 | 233.09 | 187.12 |
| Adjustment below Net Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit/Loss Balance carried down | 1,634.99 | 1,333.49 | 1,083.95 | 880.01 | 714.84 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 45.61 | 37.99 | 34.17 | 30.32 | 22.70 |
| P & L Balance carried down | 1,985.96 | 1,634.99 | 1,333.49 | 1,083.95 | 880.01 |
| Dividend | 22.81 | 18.99 | 15.19 | 15.16 | 11.35 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 400.00 | 300.00 | 250.00 | 225.00 | 200.00 |
| Dividend Per Share(Rs) | 8.00 | 6.00 | 5.00 | 4.50 | 4.00 |
| Earnings Per Share-Unit Curr | 52.18 | 44.67 | 37.35 | 30.86 | 24.78 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 269.80 | 223.81 | 183.03 | 150.19 | 122.78 |
| Book Value(Adj)-Unit Curr | 269.80 | 223.81 | 183.03 | 150.19 | 122.78 |
